Waaxda Caalamiga ah

Diseembar 3, 2024, dawada cusub ee Zepzelca (lurbinectedin oo loogu talagalay duritaanka) ayaa loo ansixiyey suuqgeynta Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) iyada oo loo marayo barnaamijka dib u eegista mudnaanta leh. Dawada waxaa loogu talagalay daaweynta bukaanada qaangaarka ah ee qaba kansarka sambabada unugyada yaryar ee aan caadiga ahayn...Akhriso wax dheeraad ah»

Diseembar 31, Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) ayaa ansixiyay VYLOYTM (zolbetuximab), oo ay weheliso kiimoterabiga fluoropyrimidine iyo platinum-ka ku jira, si loogu daaweeyo bukaanka qaba koritaanka epidermal-ka aadanaha ee aan la jari karin ama aan la jari karin...Akhriso wax dheeraad ah»

Diseembar 31, 2024, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Shirkadda") waxay ka heshay oggolaansho suuqgeyn Shiinaha Maamulka Badeecadaha Caafimaadka Qaranka (NMPA) ee ligand1 (PD-L1) ee dhimashada unugyada ee barnaamijku hago oo ah antibody monoclonal ah oo hal-abuur leh ("mAb")...Akhriso wax dheeraad ah»

C-CAR031 waa daaweyn iskiis ah oo GPC3 ah oo gaashaman oo lagu daweeyo receptor-ka antigen-ka ee T-Cell (CAR-T), kaas oo lagu baranayo daaweynta HCC. Waxay ku salaysan tahay CAR-T cusub oo GPC3 ah oo ay naqshadeysay AstraZeneca iyadoo adeegsanaysa receptor-ka beta ee II ee ugu awoodda badan ee isbeddelka koboca...Akhriso wax dheeraad ah»

Diseembar 20, 2024, Maamulka Badeecadaha Caafimaadka Qaranka ee Shiinaha (NMPA) ayaa ansixiyay Codsiga Daawada Cusub (NDA) ee DOVBLERON® (taletrectinib adipate capsule), oo ah daawada jiilka xiga ee ROS1 tyrosine kinase inhibitor (TKI), si loogu daaweeyo bukaanada qaangaarka ah ee qaba ROS-ka maxalliga ah ee horumarsan ama aan lahayn astaamo...Akhriso wax dheeraad ah»

C-CAR031 waa daaweyn iskiis ah oo GPC3 ah oo lagu tababarayo soo-dhoweeyaha antigen-ka ee T-Cell (CAR-T), oo lagu baranayo daaweynta HCC. Horumarka cilmi-baarista ee C-CAR031 ee kansarka beerka (HCC) ayaa si afka ah loogu soo bandhigay shirkii sanadlaha ahaa ee Bulshada Mareykanka ee Oncology Clinical (ASCO) ee h...Akhriso wax dheeraad ah»

GT101 waa daaweyn unug oo iskiis ah oo laga sameeyay TIL la ballaariyay oo dib loo soo nooleeyay oo laga soo saaray burooyinka bukaanka. Daaweynta waxaa lagu maamulaa iyadoo laga soo gurayo unugyada burooyinka bukaanada lana soo saarayo TIL. TIL-ka la soo saaray ayaa markaa la kordhin doonaa iyadoo la adeegsanayo goobta wax soo saarka ee gaarka loo leeyahay ee Grit Bio ee StemTe...Akhriso wax dheeraad ah»

Unugyada TAEST16001 waa unugyo T oo iskiis u shaqeysta oo hidde ahaan loo sameeyay oo muujiya soo-dhoweeyaha T-cell-ka NY-ESO-1-gaarka ah (TCR) oo bartilmaameedsanaya NY-ESO-1 (oo lagu muujiyo noocyo badan oo burooyinka ah) sarcoma-ka unugyada jilicsan ee togan (STS) marka loo eego HLA-A*02:01. Daraasad wejiga 1 ah oo lagu sameeyay bukaanada qaba S-ga horumarsan...Akhriso wax dheeraad ah»

Diseembar 04, 2024, Codsiga Daawada Cusub (NDA) ee isku-darka TYVYT® (durista sintilimab) iyo ELUNATE® (fruquintinib) ayaa laga siiyay ogolaansho shuruudaysan Shiinaha si loogu daaweeyo bukaanada qaba kansarka endometrial ee horumarsan oo leh burooyinka Mismatch Repair proficient (pMMR) kuwaas oo leh ...Akhriso wax dheeraad ah»

GC203 waa daaweyn cusub oo hidda-wadaha TIL ah oo aan fayras ahayn oo lagu sameeyay qaab-dhismeedka TIL oo la sameeyay iyadoo la adeegsanayo madal ballaarinta unugyada DeepTIL® ee gaarka loo leeyahay ee Juncell Therapeutics iyo madal wax ka beddelka hidda-wadaha NovaGMP®. DeepTIL® waxay awood u siineysaa TILs inay noqoto mid awood badan oo aan loo baahnayn isku-darka IL-2 ka dib duritaanka, iyo...Akhriso wax dheeraad ah»

Glioblastoma Multiforme (GBM) waa mid ka mid ah kansarrada ugu dilaaga badan, ku dhawaad ​​​​dhammaan bukaannadana waxay la kulmaan soo noqoshada heerka daryeelka hadda jira ee GBM-ka cusub ee la ogaaday. GBM-ka soo noqnoqda (rGBM) wuxuu muujiyaa badbaado dhexdhexaad ah oo ka yar 8 bilood iyadoo leh fursado daaweyn oo xaddidan. TX103 waa ce CAR-T ce...Akhriso wax dheeraad ah»

RD13-02 waa badeeco unug CAR-T oo caalami ah oo bartilmaameedsanaysa CD7 oo laga soo qaatay deeq-bixiyeyaal caafimaad qaba, waxaana loogu talagalay daaweynta cudurka T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) ee soo noqnoqda ama aan firfircoonayn. Waxaa hidde ahaan loo beddelay si looga fogaado cudurka fratricide, cudurka graft-versus-host (GvHD), iyo...Akhriso wax dheeraad ah»